VBC Market Dynamics
Expert articles and analysis related to vbc market dynamics.
AI Summary — Last 30 Days
The VBC market is shifting toward more sophisticated risk intermediation: third-party ACO conveners are reshaping MSSP participation by assembling geographically dispersed, high-performing provider networks, while vendors such as Arbital Health are launching tools to model downside exposure under CMS’s LEAD ACO program—signaling that actuarial, data, and capital capabilities are becoming core infrastructure for ACO strategy (Health Affairs on ACO conveners). At the same time, provider-led organizations are trying to close capability gaps through clinically integrated networks, specialty VBC models, AI-supported HCC documentation, and bundled-payment analytics, as MA enrollment remains dominant and the Trump administration’s 2027 MA rate update reinforces the continued strategic importance of Medicare risk markets. For health systems and ACO leaders, the tension is clear: scale and technical enablement are increasingly necessary to succeed in MSSP, LEAD, MA,
Related Articles
Amazon closes $3.9B One Medical deal without FTC legal challenge
From newsletter: The LI Daily: Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans ...
Providence is shutting down
From newsletter: Weekly Health Tech Reads 5/31/26 Weekly Health Tech Reads 5/31/26 Musing on $100 billion healthcare AI companies, the impact of GLP-1s, conversations about primary care access, and mo...
9amHealth Raises $26M to Expand Into Chronic Conditions Driving the Majority of Employer Pharmacy Spend
After Generating More than $50M in Projected Medical and Pharmacy Savings Across Two Fortune 100 Employers, 9amHealth is Expanding Its AI-Driven Specialty Care Platform Beyond Cardiometabolic Care to ...
Garner Health Secures $100M to Connect Patients with High-Performing Doctors
Garner Health Secures $100M to Connect Patients with High-Performing Doctors MedCity News
What CVS’s Omnicare sale means for the retail pharmacy giant
The company bought Omnicare for $12.7 billion in 2015 and is selling it for $250 million.
Policy clarity drives hospitals’ M&A surge
Hospital mergers and acquisitions (M&As) jumped in 2026 to a six-year high amid greater clarity in policies that will affect those organizations. Hospital M&A activity comes in stark contrast to other...
WakeMed declined a $5 billion merger offer
From newsletter: Weekly Health Tech Reads 5/31/26 Weekly Health Tech Reads 5/31/26 Musing on $100 billion healthcare AI companies, the impact of GLP-1s, conversations about primary care access, and mo...
Ilant Health Secures $15M to Expand Value-Based Precision Obesity Management
Ilant Health Secures $15M to Expand Value-Based Precision Obesity Management HIT Consultant
FTC clears Ascension's $3.9B AmSurg purchase, but requires some ASC divestitures
FTC clears Ascension's $3.9B AmSurg purchase, but requires some ASC divestitures Fierce Healthcare
Regulating Corporate Control in the U.S. Health Care System
Regulating Corporate Control in the U.S. Health Care System The New England Journal of Medicine